This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Aveo Pharmaceuticals, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Michael N Needle: Innovator in Cancer Treatment
Introduction
Michael N Needle is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches to therapy.
Latest Patents
Michael N Needle holds a patent for the use of tivozanib to treat subjects with refractory cancer. This patent discloses a method of treating cancer, specifically refractory cancer, by administering tivozanib as a second or third-line therapy to patients suffering from refractory advanced renal cell carcinoma. This approach is particularly valuable for patients who have not responded adequately to traditional therapies as well as more recent targeted and immune-oncology therapies.
Career Highlights
Michael N Needle is associated with Aveo Pharmaceuticals, Inc., where he continues to work on advancing cancer treatment methodologies. His expertise and dedication to improving patient outcomes have made him a key figure in the pharmaceutical industry.
Collaborations
Michael collaborates with various professionals in the field, including his coworker, Michael Bailey. Their combined efforts contribute to the ongoing research and development of effective cancer therapies.
Conclusion
Michael N Needle's innovative work in the treatment of refractory cancer exemplifies the impact of dedicated inventors in the medical field. His contributions continue to pave the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile